Sleep, Diabetic Retinopathy and Melatonin

Recruiting Phase 2 Interventional Study
Diabetes Mellitus Diabetic Retinopathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 65
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Other
Participants needed
42 (estimated)
Sponsor
University of Illinois at Chicago · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study explores the use of melatonin in patients with diabetic retinopathy

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Type 2 diabetes (clinically diagnosed, taking anti-diabetes medications or history of elevated A1C≥6.5%) * 40-65 years of age * Diabetic retinopathy of at least moderate degree Exclusion Criteria: * use of melatonin * antidepressants or antipsychotics * illicit drug use * ni…
Contacts

Sirimon Reutrakul

3129966060

sreutrak@uic.edu

CONTACT